Place of 68Ga-PSMA-11 PET-CT in the Therapeutic Decision at the End of the Initial Staging for High Risk Prostate Cancer Patients

NCT03344822 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DIAGNOSTIC_TEST: 68Ga-PSMA-11
DIAGNOSTIC_TEST: 18F-Choline PET-CT

Sponsor

Central Hospital, Nancy, France